Since 1990, this essential conference has provided a platform for viral researchers to share their research, collaborate, and network to develop novel therapeutics and host defenses against some of the deadliest diseases in biology.
This year’s program features experts from across the world, merging discussions of biophysical methods with the fundamental biology of viruses. Sessions will cover topics across structural virology, molecular biology, infection, genetics, therapeutics, and evolution, with a focus on virus-host interactions as well as viral mechanisms, replication, and egress. The agenda will also cover therapeutic advances, nanotechnology, virus evolution, and viral genomics. A special emphasis on RNA viruses such as HIV-1, Influenza, Flavivirus, and coronaviruses will be included in the agenda to reflect current global health challenges and research frontiers.